Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation (Q39751307)

14 September 2017

title

Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation (English)

1 reference

14 September 2017

1 reference

Meena Sharma

1

1 reference

14 September 2017

Robert T Ownbey

series ordinal

2

1 reference

14 September 2017

Mahesh C Sharma

series ordinal

3

1 reference

14 September 2017

language of work or name

1 reference

15 January 2010

1 reference

Experimental and Molecular Pathology

14 September 2017

published in

1 reference

14 September 2017

volume

88

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

278-286

1 reference

Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tissue plasminogen activator expression in meningiomas and glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Biology and biochemistry of proteinases in tumor invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin induces and sustains dormancy of human primary tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Annexin II represents metastatic potential in clear-cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Role of Annexin-II in GI cancers: interaction with gastrins/progastrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin receptor annexin II in vascular tumors including angiosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Increased expression of Annexin A2 in oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.001

10.1016/J.YEXMP.2010.01.001

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference